loader2
Partner With Us NRI

FDC Ltd share Price Today

Company details

456.00
469.00
304.85
489.95
6M Return 11.82%
1Y Return 48.20%
Mkt Cap.(Cr) 7,455.88
Volume 119,061
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 119,061

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals company FDC announced Q4FY24 & FY24 results:

Operating Revenue

FDC Limited reported an increase in operating revenue, with a 6.3% growth in the fourth quarter (Q4FY24) and an 8.9% growth for the full fiscal year (FY24) compared to the previous corresponding periods.

EBITDAs and Profitability

The company's EBITDA grew significantly, with an increase of 15.1% for Q4 and 34.9% for the full year. Profit after tax (PAT) for Q4FY24 was reported at Rs 46 crore, showing a growth of 50.9%, and Rs 305 crore for FY24, marking an increase of 57.4% year-over-year.

Earnings Per Share (EPS)

Earnings Per Share saw a substantial rise for both Q4FY24 and FY24, increasing by 53.7% and 59.3% respectively, indicating a strong performance by the company.

Business-wise Sales Breakdown

Domestic formulations showed growth, particularly driven by flagship brands such as Electral, Zifi, Enerzal, and Zifi-O.

US and Emerging Markets formulating businesses are also trending positively, although US formulations saw a slight decrease in the fourth quarter.

API sales exhibited a significant growth of 24.0% for the fourth quarter and an 11.9% increase for the fiscal year.

Geographical Revenue Contributions

Revenue from international operations, specifically in the US and Rest of the World (ROW) markets, has been notable, with consolidated revenue showing a 12% increase. The export formulations accounted for 15% of the total consolidated revenue.

Result PDF

View Other Company Results

FDC Ltd shares SWOT Analysis

Strengths (9)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth

Weakness (1)

  • MFs decreased their shareholding last quarter

Opportunity (0)

Data not found

Threats (0)

Data not found

Resistance and support

R1 466.0
R2 474.0
R3 479.0
Pivot

460.98

S1 453.0
S2 448.0
S3 440.0
EMA SMA
452.8
451.0
441.3
416.1
454.8
453.8
446.1
417.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
AMEYA FAMILY DISCRETIONARY TRUST Bulk Purchase 2017-03-28 203.55 16134016 BSE
ADITI FAMILY DISCRETIONARY TRUST Bulk Purchase 2017-03-28 203.55 10756110 BSE
ASHOK ANAND CHANDAVARKAR Bulk Sell 2017-03-28 203.55 16134016 BSE
Name Category Shares
NOMITA R CHANDAVARKAR PROMOTER 22.67%
NANDAN MOHAN CHANDAVARKAR (IN THE CAPACITY OF TRUSTEE OF SANDHYA MOHAN CHANDAVARKAR PROMOTER 11.01%
NANDAN MOHAN CHANDAVARKAR (IN THE CAPACITY OF TRUSTEE OF MOHAN ANAND CHANDAVARKAR PROMOTER 10.81%
AMEYA ASHOK CHANDAVARKAR PROMOTER 6.1%
NANDAN MOHAN CHANDAVARKAR PROMOTER 3.1%
ADITI C BHANOT PROMOTER 0.68%
LEO ADVISORS PVT LTD PROMOTER 9.17%
VIRGO ADVISORS PVT LTD PROMOTER 6.12%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

FDC Ltd Stocks COMPARISON

Financials( in Cr) FDC Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 457.95 1,520.95 1,574.80 4,564.50 1,078.95
% Change -0.72 0.33 0.64 -0.53 -2.76
Mcap Cr 7,455.88 364,926.86 127,144.16 121,173.33 108,567.62
Revenue TTM Cr 1,783.75 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 193.83 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 24.59 36.34 29.68 76.10 28.94
1 Year Return 48.20 54.15 60.91 30.94 102.68
ROCE 13.04 16.79 14.76 19.30 16.25
ROE 9.84 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,982.05 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,550.52 645.34
LAST 3M 103,712.87 -29,605.88
LAST 6M 176,931.00 -14,371.69
LAST 12M 290,309.13 100,312.35

FDC Ltd Information

Stock PE (TTM)
24.59
Promoter Holding
69.66%
Book Value
128.8109
ROCE
13.04%
ROE
9.84%
Description
  • FDC Ltd. is an Indian company engaged in the business of pharmaceuticals. It initiated the concept of Oral Rehydration Salts (ORS) and is now a pioneer in the segment with its brand Electral. The company was founded in 1936, with its headquarters in Aurangabad, Maharashtra. During the June 2022 quarter, its total income was Rs 513.79 crore, up 46.49% from the previous March 2022 quarter. On 27 October 2022, FDC Ltd.’s market capitalisation stood at Rs 5,006 crore.

    The company is listed on the Bombay Stock Exchange with the code FDC and on the National Stock Exchange with the code 531599.

    FDC Ltd. manufactures and distributes a range of generics, formulations, and active pharmaceutical ingredients (API) at its manufacturing plants. It also produces functional foods and beverages. Pyrimon, Cotaryl, Zifi, Enerzal, Electral, Vitcofol, Zathrin, Zoxan, Zocon, Zefu, Mycoderm, and Zipod are some of the brands owned by the company.

    On 30 June 2022, FDC Ltd.’s shareholding pattern showed public holdings of 20.1%, domestic institutional investor holdings of 6.08%, foreign institutional investor holdings of 4.34%, and promoter holdings of 69.5%. Ms Meera Ramdas Chandavarkar is the leading promoter, with a 19.4% share.

    The company’s top management comprises Mr Ramdas A Chandavarkar, Mr Nandan M Chandavarkar, Mr Ashok A Chandavarkar, Dr Mahesh Bijlani, Mr Sanjay Jain, Mr Mohan A Chandavarkar, CA Uday Kumar Gurkar, Mr Ameya A Chandavarkar, Mr Melarkode Ganesan Parameswaran, Ms Nomita R Chandavarkar, CA Swati S Mayekar, Ms Varsharani Kate, and Ms Usha Athreya Chandrasekhar. The company’s auditors are B S R & Co. LLP. As of 30 June 2022, the company’s total number of outstanding shares was 16.59 crores.

    On 27 October 2022, the company’s share price was trending at Rs 301.95 on BSE and Rs 301.75 on NSE. The company’s highest share price in 52 weeks was Rs 345, and the lowest price was Rs 225. By investing in FDC Ltd.’s shares, investors earned a six-month return of 9.26% and a one-year return of -7.97%.

    As of September 2022, ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund had a 3.21% stake in FDC Ltd. The company’s other mutual fund holdings include Tata India Pharma & Healthcare Fund, ITI Pharma and Healthcare Fund, and ICICI Prudential ESG Fund, with 2.39%, 1.93%, and 1.12% stakes, respectively.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

B-8 MIDC Industrial Area, Waluj Dist, Aurangabad (Maharashtra), Maharashtra, 431136

Tel : 91-240-2554407/967/299
Email : investors:fdcindia.com; waluj:fdcindia.com
Website : http://www.fdcindia.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 531599
NSE Code : FDC
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE258B01022

FAQ’s on FDC Ltd Shares

You can buy FDC Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy FDC Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 18, 2024 03:54 PM the closing price of FDC Ltd was Rs.457.95.

The latest PE ratio of FDC Ltd as of Jun 18, 2024 03:54 PM is 24.59

The latest PB ratio of FDC Ltd as of Jun 18, 2024 03:54 PM is 0.28

The 52-week high of FDC Ltd share price is Rs. 489.95 while the 52-week low is Rs. 304.85

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 18, 2024 03:54 PM, the market cap of FDC Ltd stood at Rs. 7,455.88.

Download App

Download Our App

Play Store App Store
market app